The National Security Commission on Emerging Biotechnology is visiting Pittsburgh to talk about how biotechnology and ...

AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, smarter path to launch.

Despite a wave of AI-fueled layoffs, the pharma and biotech industries could be spared from massive cutbacks for now.

AI search is fundamentally changing how consumers navigate decision making, and brands must adapt in order to be discoverable.

DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...

This article was originally published in Just Security.

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...

Hybrid modelling and simulations reduce lab testing and speed up discovery. The global AI in biotechnology market was valued ...

Kiran Mazumdar-Shaw said India must build biotech sovereignty powered by AI to protect health security and lead the future of medicine ...

The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...